Drug-induced Dyskinesia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-08-06
Clinical Trial Update: Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy [Phase 2, Phase 3]
An open-label safety study of Dipraglurant (ADX48621) in Parkinson's disease patients receiving levodopa-based therapy has been terminated (…